Insights and therapeutics: Parkinson’s disease

No cure has been identified to Parkinson’s disease, but use of drugs can slow down the progression. Normally prescribed by physicians include change of life style, regular aerobic exercise and prescribed therapeutic supplement. It is noted that people will have beneficial effect who are taking co-enzyme Q10 during their initial stage of disease. It is unclear how genetical changes cause Parkinson disease or influence the risk of developing the disorder. Some gene mutations(alterations) such as LRRK 2, PARK 7, PINK 1, PRKN disturb the cell mechanism that breaks down undesired proteins in neurons which are responsible for dopamine production. Hence, undegraded proteins accumulate, resulting in death of vital nerve cells and subsequently lowers the level of dopamine production. In most cases of Parkinson disease, protein deposits called Lewy bodies. It is unclear whether Lewy bodies play a key role in killing nerve cells or just part of the cells which are responsible to the disease. Yoga, massage, acupuncture, meditation, music or art therapy, alexander technique is also regarding as best methods to control neurological disorders particularly Parkinson’s disease, Alzheimer’s and neuropsychiatric. Tetrabenazine, neuroleptics, mirtazapine can be taken to for treating chorea.

 

  • Dopamine Agonists
  • Anticholinergics
  • COMT Inhibitors

Related Conference of Insights and therapeutics: Parkinson’s disease

February 28 – March 01, 2019

28th World Congress on Neurology and Therapeutics

Golden Tulip Berlin – Hotel Hamburg, Berlin, Germany
March 14-15, 2019

Annual Congress on Neurology & Neuroscience

Paris, France
March 18-19, 2019

World Depression Congress

Dubai, UAE
March 20-21, 2019

11th World Congress on Alzheimers Disease & Dementia

Sydney, Australia
March 25-26, 2019

31st World Congress on Neurology & Neuroscience

Osaka, Japan
April 11-12, 2019

International Conference on Neurology & Mental Disorders

Stockholm, Sweden
May 15-16, 2019

14th World Congress on Advances in Alzheimers and Dementia

Melbourne, Australia
May 23-24, 2019

28th World Congress on Neurology & Neuroscience

Zurich, Switzerland
June 13-14, 2019

2nd World Congress on Epilepsy and Brain Disorders

Helsinki, Finland
June 17-18, 2019

19th Global Neuroscience Conference

| Novotel | Brisbane, Australia
June 20-21, 2019 Dubai, UAE

26th Cognitive Neuroscience Congress

July 22-24, 2019

32nd European Neurology Congress

London, UK
August 12-13, 2019

4th World Congress on Pediatric Neurology and Pediatric Surgery

Auckland, New Zealand
August 12-13, 2019

14th International Conference on Neurology and Brain Disorders

Auckland, New Zealand
August 29-30, 2019

5th International Conference on Epilepsy & Treatment

Vienna, Austria
August 29-30, 2019

5th International Conference on Epilepsy & Treatment

Vienna, Austria
August 29-31, 2019

5th World Congress on Parkinsons & Huntington Disease

Vienna, Austria
September 11-12, 2019

6th International Conference on Dual Diagnosis Disorders

| Holiday Inn Atrium | Singapore
October 21-22, 2019

World Congress on Advances in Brain Injury, Disorders and Therapeutics

| Radisson Hotel Narita, Tokyo, Japan
October 24-25, 2019

Euro Neonatology 2019

Praugue, Czech Republic
Oct 30-31, 2019

5th Global Experts Meeting on Parkinsons, Huntingtons & Movement Disorders

Radisson Hotel Narita, Tokyo, Japan
October 30-31, 2019

6th World Congress on Spine and Spinal Disorders

| Radisson Hotel Narita | Tokyo,Japan
November 18-19, 2019

14th Annual Conference on Dementia and Alzheimers Disease

Johannesburg, South Africa
November 19-20, 2019

32nd Clinical Neuroscience and Neurogenetics Conference

Istanbul, Turkey
November 21-22 2019

2nd World Neuron Congress

Bali, Indonesia
November 28-29, 2019

6th Annual Conference on Stroke and Neurological Disorders

Bucharest, Romania
December 05-06, 2019

2nd World Brain Congress

Abu Dhabi

Insights and therapeutics: Parkinson’s disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in